ARROWHEAD PHARMACEUTICALS IN (ARWR)

US04280A1007 - Common Stock

21.05  +2.26 (+12.03%)

After market: 21.6696 +0.62 (+2.94%)

News Image
5 hours ago - Arrowhead Pharmaceuticals, Inc.

Arrowhead Pharmaceuticals Reports 2024 Fiscal Year-End Results

News Image
10 hours ago - Chartmill

The market is buzzing with gapping stocks on Tuesday. Let's uncover which stocks are experiencing notable gaps during today's session.

Today's session on Tuesday is marked by notable gaps in various stocks. Stay informed with the gap up and gap down stocks in today's session.

News Image
11 hours ago - Investor's Business Daily

Arrowhead Launches 25% On A Massive Licensing Deal With Sarepta

The deal focuses on four clinical-stage drugs, three preclinical assets and a potential five new targets.

News Image
12 hours ago - Chartmill

Which stocks are moving before the opening bell on Tuesday?

Let's have a look at what is happening on the US markets before the opening bell on Tuesday. Below you can find the top gainers and losers in today's pre-market session.

News Image
22 days ago - Arrowhead Pharmaceuticals, Inc.

Arrowhead Pharmaceuticals to Webcast 2024 Fiscal Year End Results

News Image
a month ago - Market News Video

First Week of ARWR June 2025 Options Trading

News Image
a month ago - Investor's Business Daily

Avidity Biosciences, Up 441%, Nears Another Record High As Dystrophy Space Heats Up

The company is working on treatments for forms of muscular dystrophy, and is taking on some of the biggest names in pharma.

News Image
4 months ago - InvestorPlace

ARWR Stock Earnings: Arrowhead Pharma Misses EPS for Q3 2024

ARWR stock results show that Arrowhead Pharma missed analyst estimates for earnings per share the third quarter of 2024.

News Image
4 months ago - BusinessInsider

ARWR Stock Earnings: Arrowhead Pharma Misses EPS for Q3 2024

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Arrowhead Pharma (NASDAQ:ARWR) just reported results for the third quarter of 2...

News Image
4 months ago - Arrowhead Pharmaceuticals, Inc.

Arrowhead Pharmaceuticals Reports Fiscal 2024 Third Quarter Results

News Image
5 months ago - Market News Video

ARWR Crosses Above Key Moving Average Level

News Image
5 months ago - Investor's Business Daily

What The Quest For New Cholesterol Treatments Means For Novartis, Merck — And Patients

A number of companies are working on new drugs for high lipids, including cholesterol and triglycerides.

News Image
5 months ago - InvestorPlace

Have 20 Bucks? 7 Low-Priced Stocks That Could Double by 2025

Low priced stocks to buy for growth provide great value to investors in the $20 range and are expected to pop before 2025.